Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]
ESMO Open. 2024 Oct;9(10):103705.
doi: 10.1016/j.esmoop.2024.103705.
Epub 2024 Aug 29.
1 Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg.
2 Department of Medical Oncology, Bridge Institute of Experimental Tumor Therapy, University Medicine Essen, Essen; Division of Solid Tumor Translational Oncology (DKTK Partner Site Essen, DKFZ Heidelberg), West German Cancer Center, University Medicine Essen, Essen.
3 Comprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.
4 Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg and University Cancer Center Hamburg (UCCH), Hamburg, Germany.
5 Department of Internal Medicine 5, Hematology and Medical Oncology, Paracelsus Medical University, Nürnberg.
6 Department of Internal Medicine III, SLK-Clinics Heilbronn GmbH, Heilbronn.
7 Department of Gastroenterology and Hepatology, University Hospital Cologne, Cologne.
8 Division of Oncology and Hematology, Charité Campus Mitte, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin.
9 Clinic for Gastroenterology, Hepatology and GI-Oncology, München Klinik Bogenhausen, Munich.
10 Department of Internal Medicine I, Kliniken Nordoberpfalz AG, Klinikum Weiden, Weiden.
11 Department of Medical Oncology and Comprehensive Cancer Center, Ludwig Maximilians University-Grosshadern, Munich.
12 Department of Internal Medicine I, Ulm University Hospital, Ulm.
13 Department of Biometrics, ClinAssess GmbH, Leverkusen.
14 Clinical Research, AIO Studien gGmbH, Berlin.
15 Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery and Comprehensive Cancer Center Mainfranken Würzburg, University Hospital Würzburg, Würzburg.
16 Department of Haematology, Oncology and Palliative Care Medicine, Asklepios Hospital Barmbek, Hamburg, Germany.
17 Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg. Electronic address: [email protected].